Skip to main content

Table 3 Literature review of peripheral T cell lymphoma

From: Primary non-Hodgkin lymphoma of the tongue base: the clinicopathology of seven cases and evaluation of HPV and EBV status

NameyearNumberof CasesAge/sexPrimary site of tongueCytologic FeaturesIHC characters and gene rearrangmentClinical featureStageIPITreatmentSurvival (months)
Uherova P,et al. [12]2002156/Msmall to intermediate, with round nuclei and abundant pale to clear cytoplasm, like marginal zone B-Cell lymphomaCD3+,CD43+,CD45+; TCR+
May SA, et al. [13]2007140/Fright ventrolateatypical small- to medium-sized lymphoid infiltrate with involvement of the overlying squamous epithelium. Having irregular nuclear contours and scant cytoplasmCD2,3,4,5+ CD43+; TCR+ Ki-67 25%noduleIALowCVD and CM32 months free of disease until research published
Lee JH, et al. [14]2014159/Mright side of the tongue baseCD3+, TIA+, granzyme B+ CD56-Ki-67 80%fungating massIIAlowCHOP plus RT and VMATDied 17 months later
Narla S, et al. [15]2016150/Fleft half of anterior portionsmall lymphoid cells with scanty cytoplasm, irregular hyperchromatic nucleusand inconspicuous nucleoliCD3,4,8+;TCR+Ki67 30–40%noduleIlowNo adjunctive therapy1 year later lost followed up
  1. F: female; M: male; TCR: T cell rearrangement; CVD: cyclophosphamide, vincristine, anddexamethasone; CM: cytarabine and methotrexate; −: not mentioned;
  2. CHOP: C-cyclophosphamide H-doxorubicin (hydroxydaunomycin) O-vincristine P- prednisolone; RT: radiation therapy; VMAT: volumetric modulated arc therapy